Deciphering mechanisms of Listeria placental-fetal invasion

破译李斯特菌胎盘-胎儿侵袭机制

基本信息

项目摘要

Project Summary Listeria monocytogenes (Lm) is a facultative gram-positive intracellular bacterium that causes infection in humans via ingestion of contaminated food. Severe infection can occur in elderly and immunocompromised patients well as in pregnant women and neonates. Infection can lead to meningitis, meningoencephalitis, brain abscess, and, for pregnant women, abortion, still-birth, and disseminated fetal infection. The high mortality rate of invasive Lm disease despite antibiotic treatment highlights the need for new effective therapeutic strategies for managing Lm infections. Previous studies have shown that distinct isolates of Lm can exhibit different tissue tropisms, resulting in the acquisition of novel target organ replication niches. A clinical Lm isolate, 07PF0776, was found to have an enhanced ability to target cardiac tissue based on amino acid variations present within InlB, a bacterial surface protein associated with host cell invasion. These amino acid variations appear to increase stability and promote binding to host surface heparin sulfate moieties, which results in recruitment of InlB to the host cell surface and stimulation of Met, the receptor bound by InlB. The Met receptor is abundantly expressed by placental tissue and is required for embryonic and placental development. Preliminary data has shown at least two Lm cardiotropic strains expressing the InlB variant exhibit significantly enhanced vertical transmission. We hypothesize that modification of InlB can expand the tissue repertoire of Lm and enhance invasion through the manipulation of Met signaling pathways, leading to increased rates of fetal transmission. The specific aims of this proposal will undertake a functional assessment of Lm InlB variant strains to examine their efficacy of vertical transmission as well as determine the mechanisms by which overexpression and/or increased stability of InlB increases vertical transmission. Aim 1 will undertake a functional assessment of cardiotropic strains for efficiency of vertical transmission to define and identify strains of Lm that pose an enhanced risk for fetal disease. Aim 2 will determine the mechanisms by which overexpression of InlB increases Lm vertical transmission. These studies will thus clarify how select Lm isolates gain access with high efficiency to placental/fetal tissues to cause devastating forms of neonatal disease and death.
项目概要 单核细胞增生李斯特菌 (Lm) 是一种兼性革兰氏阳性细胞内细菌,可引起 人类通过摄入受污染的食物而受到感染。严重感染可发生在老年人和 免疫功能低下的患者以及孕妇和新生儿。感染可能导致 脑膜炎、脑膜脑炎、脑脓肿,以及孕妇的流产、死产和 胎儿播散性感染。尽管使用抗生素,侵袭性 Lm 病的死亡率仍然很高 治疗强调需要新的有效治疗策略来控制 Lm 感染。 先前的研究表明,Lm 的不同分离株可以表现出不同的组织向性,从而导致 获得新的靶器官复制生态位。发现临床 Lm 分离株 07PF0776 根据体内存在的氨基酸变化,增强靶向心脏组织的能力 InlB,一种与宿主细胞侵袭相关的细菌表面蛋白。这些氨基酸变异 似乎增加了稳定性并促进与宿主表面硫酸肝素部分的结合,这 导致 InlB 募集到宿主细胞表面并刺激 Met(Met 结合的受体) InlB。 Met 受体在胎盘组织中大量表达,是胚胎和胚胎发育所必需的。 胎盘发育。初步数据显示至少有两种 Lm 心肌菌株表达 InlB 变体表现出显着增强的垂直传输。我们假设修改 InlB 可以扩展 Lm 的组织库并通过操纵 Met 增强侵袭 信号通路,导致胎儿传播率增加。本提案的具体目标 将对 Lm InlB 变异菌株进行功能评估,以检查其垂直治疗的功效 传播以及确定过度表达和/或增加稳定性的机制 InlB 增加垂直传输。目标 1 将进行心脏功能评估 垂直传播效率的应变来定义和识别 Lm 的应变,这些应变构成了 胎儿患病的风险增加。目标 2 将确定过度表达的机制 InlB 增加 Lm 垂直传输。因此,这些研究将阐明选择 Lm 如何隔离增益 高效接触胎盘/胎儿组织,导致毁灭性的新生儿疾病 和死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nancy Elizabeth Freitag其他文献

Nancy Elizabeth Freitag的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nancy Elizabeth Freitag', 18)}}的其他基金

Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10363099
  • 财政年份:
    2022
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10646152
  • 财政年份:
    2022
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇​​静剂选择对肺炎克雷伯菌肺部感染动态的影响
  • 批准号:
    10350966
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering the impact of sedative choice on the dynamics of Klebsiella pneumoniae lung infection
解读镇​​静剂选择对肺炎克雷伯菌肺部感染动态的影响
  • 批准号:
    10527379
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering mechanisms of Listeria placental-fetal invasion
破译李斯特菌胎盘-胎儿侵袭机制
  • 批准号:
    10436619
  • 财政年份:
    2021
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
  • 批准号:
    8806236
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering how bacterial pheromone signaling enhances Listeria virulence
破译细菌信息素信号如何增强李斯特菌毒力
  • 批准号:
    8965502
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
  • 项目类别:
21st Annual Midwest Microbial Pathogenesis Conference
第21届年度中西部微生物发病机制会议
  • 批准号:
    8785218
  • 财政年份:
    2014
  • 资助金额:
    $ 23.99万
  • 项目类别:
Deciphering how anesthetics increase host susceptibility to microbial infection
破译麻醉剂如何增加宿主对微生物感染的易感性
  • 批准号:
    8462202
  • 财政年份:
    2012
  • 资助金额:
    $ 23.99万
  • 项目类别:
Listeria virulence gene expression within host cells
宿主细胞内李斯特菌毒力基因的表达
  • 批准号:
    8524135
  • 财政年份:
    2012
  • 资助金额:
    $ 23.99万
  • 项目类别:

相似海外基金

SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
  • 批准号:
    2213034
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
  • 批准号:
    10645528
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
  • 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
  • 批准号:
    10736285
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
  • 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
  • 批准号:
    10603486
  • 财政年份:
    2023
  • 资助金额:
    $ 23.99万
  • 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
  • 批准号:
    449379
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
  • 批准号:
    422034
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
  • 批准号:
    nhmrc : 1197866
  • 财政年份:
    2020
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
  • 批准号:
    2241853
  • 财政年份:
    2019
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
  • 批准号:
    18K07106
  • 财政年份:
    2018
  • 资助金额:
    $ 23.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
  • 批准号:
    9788269
  • 财政年份:
    2018
  • 资助金额:
    $ 23.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了